Five weeks after Aquablation, the patient is passing bright‑red urine with two clots; what immediate actions should he take and should he remain supine or stand?

Immediate Management of Post-Aquablation Bleeding at 5 Weeks

The patient should immediately contact their urologist or go to the emergency department for evaluation, as bright red urine with clots 5 weeks post-Aquablation represents delayed bleeding that may require intervention; the patient should remain at rest (lying down or sitting) and avoid strenuous activity until evaluated.

Immediate Actions

Patient Positioning and Activity

• Lie down or sit quietly – avoid standing or walking unnecessarily, as upright positioning and activity can increase bleeding
• Cease all physical exertion immediately
• Maintain adequate hydration to help flush the bladder

Urgent Medical Evaluation Required

This presentation warrants immediate assessment because:

• Delayed bleeding (5 weeks post-procedure) can indicate pseudoaneurysm rupture, arteriovenous fistula, or delayed vessel injury 1
• Bright red blood with clots suggests active arterial or significant venous bleeding
• Post-Aquablation bleeding complications occur in 0.2-25% of cases depending on technique and prostate size 2, 3

Clinical Assessment Framework

Hemodynamic Stability Determination

The treating physician must immediately assess:

• Vital signs: Heart rate, blood pressure (shock index = HR/systolic BP; unstable if >1) 4
• Volume of bleeding: Continuous vs. intermittent, clot size and frequency
• Hemoglobin level: Baseline comparison essential 5

Risk Stratification

High-risk features requiring immediate intervention:

• Hemodynamic instability (shock index >1)
• Continuous bright red bleeding
• Large clots causing retention
• Hemoglobin drop >2 g/dL
• Inability to void due to clot obstruction

Management Algorithm

For Hemodynamically Stable Patients

1. Urethral catheter placement with continuous bladder irrigation if not already present 5
2. CT angiography if bleeding persists despite irrigation – fastest method to localize bleeding source 4, 5
3. Cystoscopy with fulguration if bleeding point identified and accessible 2, 6
4. Angioembolization if CT shows vascular extravasation or pseudoaneurysm 5

For Hemodynamically Unstable Patients

1. Immediate resuscitation with IV access and fluid replacement
2. Restrictive transfusion threshold: Hemoglobin trigger 70 g/L (target 70-90 g/L), or 80 g/L trigger (target 100 g/L) if cardiovascular disease present 4
3. Urgent CT angiography to localize bleeding source 4, 5
4. Interventional radiology consultation for angioembolization within 60 minutes if available 4
5. Cystoscopy with clot evacuation and fulguration if angiography negative or unavailable

Aquablation-Specific Considerations

Bleeding Patterns

• Early bleeding (first 2 weeks): Usually responds to catheter traction or conservative management
• Delayed bleeding (>2 weeks): More concerning for secondary hemorrhage from pseudoaneurysm or arteriovenous fistula rupture 1
• Larger prostates (>80 mL) have higher bleeding risk 2, 7

Common Pitfalls

• Do not assume self-limited bleeding at 5 weeks post-procedure – this timing suggests vascular complication
• Avoid empiric observation without catheter placement if clots present
• Do not delay imaging if bleeding continues despite bladder irrigation
• Check anticoagulation/antiplatelet status – may need reversal if life-threatening 4, 8

Anticoagulation Management (If Applicable)

If patient is on anticoagulation:

• Warfarin: Reverse with prothrombin complex concentrate and vitamin K if unstable 4
• Antiplatelet agents: Generally continue aspirin unless life-threatening bleeding; consider platelet transfusion if severe 8
• NOACs: Delay 24-36 hours if possible; consider reversal agents if unstable 8

Follow-up Imaging

After stabilization, contrast-enhanced ultrasound or CT with delayed phase at 48 hours to exclude ongoing vascular injury or urinoma 1

The key distinction here is that bleeding at 5 weeks is not typical post-operative oozing but rather suggests a specific vascular complication requiring targeted intervention rather than expectant management.